-
Chuanxiong Cortex and Pith: Volatile Mechanisms in CHD
2026-09-03
The reference study combines SPME-GC×GC-MS, network pharmacology, and molecular docking to distinguish volatile constituents and predicted coronary heart disease mechanisms in the cortex and pith of Ligusticum chuanxiong. Its identification of Fenipentol among the principal cortex-associated candidates provides a testable starting point for chemical validation, while the computational results should be interpreted as mechanistic hypotheses rather than clinical proof.
-
From Genotype to Mechanism: Faster Mouse Models
2026-09-03
Rapid genotyping is more than a throughput advantage: it can determine how quickly researchers move from an engineered allele to a defensible mechanistic model. This thought-leadership article connects direct mouse tissue PCR with recent evidence that scaRNA1 disruption alters U2 pseudouridylation and transcript isoforms, while defining the workflow boundaries that matter for translational studies.
-
TNF-alpha recombinant murine protein in apoptosis assays
2026-09-02
Use TNF-alpha recombinant murine protein as a sensitive, orthogonal stimulus for apoptosis, inflammatory signaling, and receptor-pathway studies. This workflow combines quantitative dose finding with the latest RNA Pol II degradation-dependent apoptosis model to help distinguish active death signaling from passive transcriptional failure.
-
M-CSF as a Translational Lever in Macrophage Fibrosis
2026-09-02
A mechanistic and experimental framework for using Recombinant Mouse Macrophage Colony Stimulating Factor to standardize macrophage models, interrogate the IGF2BP1–THBS1–TLR4 axis, and improve translational fibrosis research.
-
Recombinant Mouse SHH: Mechanism & Workflow
2026-09-01
Recombinant Mouse Sonic Hedgehog is a bioactive SHH protein for research on developmental patterning and hedgehog signaling pathway function. Its product-defined benchmark is an ED50 of 0.5–1.0 μg/ml in a murine C3H10T1/2 alkaline phosphatase induction assay.
-
Amitriptyline HCl: Practical Lab Workflow
2026-09-01
Amitriptyline HCl (B2231) provides a defined small-molecule reference for in vitro studies of neurotransmitter receptor modulation, with documented potency, solubility, identity, and storage specifications. It is suitable for controlled neuropharmacology and mood disorder research workflows, but the dossier does not establish disease efficacy, BBB penetration, or long-term solution stability.
-
BQCA and the Next Logic of M1 Signaling
2026-08-31
Benzyl Quinolone Carboxylic Acid (BQCA) illustrates how selective allosteric control of M1 muscarinic signaling can connect receptor pharmacology with neuronal validation and translational strategy.
-
SP600125: Practical JNK Inhibitor Workflows
2026-08-31
SP600125 provides a reversible, ATP-competitive way to test how JNK signaling influences c-Jun phosphorylation, apoptosis, inflammation, and cytokine expression. This guide translates its biochemical and cellular performance into controlled workflows, assay controls, and troubleshooting decisions for mechanism-focused research.
-
Tranexamic Acid in Instant Clot-Forming Dressings
2026-08-30
This study developed a bi-layer wound dressing that combines Tranexamic Acid, nitric oxide release, and propolis to address hemorrhage and bacterial contamination simultaneously. The formulation promoted early clot formation, stabilized a dense fibrin network, and reduced bacterial colony counts in material-based assays, while still requiring in vivo and clinical validation.
-
From Mouse Genotype to Mechanism: A Translational Edge
2026-08-29
A thought-leadership guide to using rapid, direct mouse genotyping as a foundational quality-control layer in mechanistic studies such as iTBS research in SCA3/MJD mice.
-
Landscape of Plastid DNA Breaks in Arabidopsis
2026-08-28
The reference study uses DNA end tailing and sequencing (DEtail-seq) to map plastid DNA breaks across Arabidopsis development, genetic backgrounds, and environmental conditions. Its results identify developmental accumulation, ribosomal DNA vulnerability, repair-pathway dependence, and links between R-loops, reactive oxygen species, and plastid genome damage.
-
SHH, FGF10, and Species-Specific Penile Development
2026-08-28
The 2025 Cells study identifies differential Shh, Fgf10, and Fgfr2 expression as a central explanation for why mice form a largely closed urethral plate whereas guinea pigs develop an open urethral groove. By combining comparative gene-expression analysis with genital-tubercle organ culture, the authors connect species-specific molecular programs to distinct preputial and urethral morphogenetic outcomes.
-
TNF-alpha, recombinant murine protein
2026-08-27
A scenario-based guide to using TNF-alpha, recombinant murine protein (SKU P1002) in viability, proliferation, cytotoxicity, and apoptosis workflows. It connects product-specific potency, formulation, storage, and assay design with recent evidence that regulated cell death can arise from active signaling rather than passive loss of transcription.
-
CUDC-907 Dual PI3K/HDAC Inhibitor Workflow
2026-08-27
CUDC-907 (SKU A4097) is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, apoptosis, and cell-cycle responses. This dossier-based guidance supports cell and biochemical assay planning but does not establish clinical, diagnostic, or therapeutic use.
-
Annular Sector Microneedles for Glaucoma Gene Therapy
2026-08-26
The reference study develops an annular sector-shaped microneedle patch that locally co-delivers nicotinamide and Nmnat1 gene-loaded lipid nanoparticles to the trabecular meshwork. In human trabecular meshwork cells and a dexamethasone-induced mouse model, this strategy improved NAD+ biology, mitochondrial homeostasis, intraocular pressure, and fibrosis-related outcomes, supporting a disease-modifying approach to glaucoma.